Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer

(2015) Paul R. Womble et al.   EUROPEAN UROLOGY

Trends in Management for Patients With Localized Prostate Cancer, 1990-2013

(2015) Matthew R. Cooperberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

(2014) Andrew J Vickers et al.   BMC Medicine

National trends in prostate cancer screening among older American men with limited 9-year life expectancies: Evidence of an increased need for shared decision making

(2014) Michael W. Drazer et al.   CANCER

It Ain’t What You Do, It's the Way You Do It: Five Golden Rules for Transforming Prostate-Specific Antigen Screening

(2014) Andrew Vickers et al.   EUROPEAN UROLOGY

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

A Systematic Review of the Volume–Outcome Relationship for Radical Prostatectomy

(2013) Quoc-Dien Trinh et al.   EUROPEAN UROLOGY

Early Detection of Prostate Cancer: AUA Guideline

(2013) H. Ballentine Carter et al.   JOURNAL OF UROLOGY

Declines in Prostate Cancer Incidence After Changes in Screening Recommendations

(2012) David H. Howard   ARCHIVES OF INTERNAL MEDICINE

Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review

(2012) Sigrid Carlsson et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quality-of-Life Effects of Prostate-Specific Antigen Screening

(2012) Eveline A.M. Heijnsdijk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population-Based Patterns and Predictors of Prostate-Specific Antigen Screening Among Older Men in the United States

(2011) Michael W. Drazer et al.   JOURNAL OF CLINICAL ONCOLOGY

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

(2011) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

(2010) A. J. Vickers et al.   CLINICAL CANCER RESEARCH

Cancer Control and Functional Outcomes After Radical Prostatectomy as Markers of Surgical Quality: Analysis of Heterogeneity Between Surgeons at a Single Cancer Center

(2010) Andrew Vickers et al.   EUROPEAN UROLOGY

Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer

(2010) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer

(2009) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute

Low Annual Caseloads of United States Surgeons Conducting Radical Prostatectomy

(2009) Caroline J. Savage et al.   JOURNAL OF UROLOGY

Estimating the benefits of PSA screening

(2009) Andrew J. Vickers et al.   Nature Reviews Urology

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Do high-volume hospitals and surgeons provide better care in urologic oncology?

(2009) James A. Eastham   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

(2008) Martin G. Sanda et al.   NEW ENGLAND JOURNAL OF MEDICINE